To estimate the robustness of the choice for the upper limit of 10 potential regulators in our MIPRIP analysis, we investigated models with other limits (1 up to 50 regulators) and tested them using the melanoma skin cancer samples with a TERT promoter mutation. This evidence concerns the gene TERT and melanoma.